AbCellera Biologics Inc (ABCL)
3.825
-0.12
(-3.16%)
USD |
NASDAQ |
May 10, 16:00
3.825
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Price: 3.825 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 09, 2024 | 3.86 | 4.015 | 3.85 | 3.95 | 979369.0 |
| May 08, 2024 | 4.04 | 4.199 | 3.78 | 3.84 | 1.334M |
| May 07, 2024 | 4.12 | 4.28 | 3.99 | 4.04 | 2.176M |
| May 06, 2024 | 4.14 | 4.175 | 4.03 | 4.11 | 1.824M |
| May 03, 2024 | 3.92 | 4.20 | 3.92 | 4.03 | 2.203M |
| May 02, 2024 | 3.89 | 3.89 | 3.68 | 3.85 | 1.238M |
| May 01, 2024 | 3.77 | 3.96 | 3.655 | 3.78 | 2.009M |
| Apr 30, 2024 | 3.82 | 4.00 | 3.725 | 3.78 | 935475.0 |
| Apr 29, 2024 | 3.78 | 3.860 | 3.762 | 3.84 | 1.426M |
| Apr 26, 2024 | 3.69 | 3.80 | 3.64 | 3.76 | 1.370M |
| Apr 25, 2024 | 3.86 | 3.880 | 3.62 | 3.63 | 1.830M |
| Apr 24, 2024 | 4.01 | 4.25 | 3.89 | 3.90 | 1.599M |
| Apr 23, 2024 | 4.00 | 4.31 | 3.965 | 3.97 | 1.595M |
| Apr 22, 2024 | 3.89 | 4.01 | 3.83 | 4.01 | 1.076M |
| Apr 19, 2024 | 3.85 | 3.96 | 3.79 | 3.87 | 978622.0 |
| Apr 18, 2024 | 3.95 | 3.97 | 3.84 | 3.91 | 765647.0 |
| Apr 17, 2024 | 4.06 | 4.15 | 3.92 | 3.92 | 1.069M |
| Apr 16, 2024 | 4.13 | 4.15 | 4.03 | 4.05 | 1.272M |
| Apr 15, 2024 | 4.34 | 4.34 | 4.15 | 4.18 | 1.359M |
| Apr 12, 2024 | 4.35 | 4.42 | 4.25 | 4.34 | 1.011M |
| Apr 11, 2024 | 4.50 | 4.56 | 4.33 | 4.38 | 1.051M |
| Apr 10, 2024 | 4.53 | 4.65 | 4.38 | 4.46 | 1.034M |
| Apr 09, 2024 | 4.51 | 4.750 | 4.47 | 4.73 | 1.299M |
| Apr 08, 2024 | 4.38 | 4.535 | 4.35 | 4.49 | 857034.0 |
| Apr 05, 2024 | 4.36 | 4.45 | 4.26 | 4.34 | 769782.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.63
Minimum
Apr 25 2024
58.90
Maximum
Dec 11 2020
13.46
Average
9.91
Median
Price Benchmarks
| Acasti Pharma Inc | 2.76 |
| Aurinia Pharmaceuticals Inc | 5.025 |
| Edesa Biotech Inc | 4.55 |
| Lexaria Bioscience Corp | 3.57 |
| InMed Pharmaceuticals Inc | 0.2632 |
Price Related Metrics
| PS Ratio | 29.08 |
| Price to Book Value | 0.9761 |
| Earnings Yield | -13.59% |
| Market Cap | 1.125B |